115 related articles for article (PubMed ID: 28758939)
1. Stonin 2 Overexpression is Correlated with Unfavorable Prognosis and Tumor Invasion in Epithelial Ovarian Cancer.
Sun X; Zhang W; Li H; Niu C; Ou Y; Song L; Zhang Y
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758939
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
3. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
5. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.
Bignotti E; Todeschini P; Calza S; Falchetti M; Ravanini M; Tassi RA; Ravaggi A; Bandiera E; Romani C; Zanotti L; Tognon G; Odicino FE; Facchetti F; Pecorelli S; Santin AD
Eur J Cancer; 2010 Mar; 46(5):944-53. PubMed ID: 20060709
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
[TBL] [Abstract][Full Text] [Related]
7. UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis.
Yang Y; Jiang Y; Wan Y; Zhang L; Qiu J; Zhou S; Cheng W
Tumour Biol; 2016 Aug; 37(8):10633-41. PubMed ID: 26867765
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG20 predicts a poor prognosis and promotes cell progression in epithelial ovarian cancer.
Wang D; Dai J; Hou S; Qian Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30846486
[TBL] [Abstract][Full Text] [Related]
9. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
Zhang Y; Hua W; Niu LC; Li SM; Wang YM; Shang L; Zhang C; Li WN; Wang R; Chen BL; Xin XY; Zhang YQ; Wang J
Tumour Biol; 2016 Jul; 37(7):9423-31. PubMed ID: 26781874
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of kinesin family member 20A is associated with unfavorable clinical outcome and tumor progression in epithelial ovarian cancer.
Li H; Zhang W; Sun X; Chen J; Li Y; Niu C; Xu B; Zhang Y
Cancer Manag Res; 2018; 10():3433-3450. PubMed ID: 30254487
[TBL] [Abstract][Full Text] [Related]
11. Expression of RRBP1 in epithelial ovarian cancer and its clinical significance.
Ma J; Ren S; Ding J; Liu S; Zhu J; Ma R; Meng F
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31285390
[TBL] [Abstract][Full Text] [Related]
12. Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma.
Sung PL; Jan YH; Lin SC; Huang CC; Lin H; Wen KC; Chao KC; Lai CR; Wang PH; Chuang CM; Wu HH; Twu NF; Yen MS; Hsiao M; Huang CY
Oncotarget; 2016 Jan; 7(4):4036-47. PubMed ID: 26716408
[TBL] [Abstract][Full Text] [Related]
13. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer.
Liu L; Zeng Z; Yi J; Zuo L; Lv J; Yuan J; Lin Z; Luo R; Feng X
Cancer Biomark; 2019; 24(2):213-221. PubMed ID: 30614797
[TBL] [Abstract][Full Text] [Related]
15. Stonin 2 activates lysosomal-mTOR axis for cell survival in oral cancer.
Mahapatra KK; Mishra SR; Dhiman R; Bhutia SK
Toxicol In Vitro; 2023 Apr; 88():105561. PubMed ID: 36702439
[TBL] [Abstract][Full Text] [Related]
16. LAMP3 expression correlated with poor clinical outcome in human ovarian cancer.
Wang D; Cao X; Zhang Y; Liu Y; Yao C; Ge W; Xu Y
Tumour Biol; 2017 Mar; 39(3):1010428317695014. PubMed ID: 28349821
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
18. Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.
Mignogna C; Staropoli N; Botta C; De Marco C; Rizzuto A; Morelli M; Di Cello A; Franco R; Camastra C; Presta I; Malara N; Salvino A; Tassone P; Tagliaferri P; Barni T; Donato G; Di Vito A
J Ovarian Res; 2016 May; 9(1):31. PubMed ID: 27209210
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
20. Biological role and prognostic significance of NAC1 in ovarian cancer.
Nakayama K; Rahman MT; Rahman M; Yeasmin S; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gynecol Oncol; 2010 Dec; 119(3):469-78. PubMed ID: 20869761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
